RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
29.27
-4.26 (-12.71%)
Oct 22, 2025, 1:16 PM EDT - Market open
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $484.06 million as of October 22, 2025. Its market cap has increased by 593.43% in one year.
Market Cap
484.06M
Enterprise Value
329.36M
1-Year Change
593.43%
Ranking
Category
Stock Price
$29.27
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has increased from $276.64M to $484.06M, an increase of 74.98%. That is a compound annual growth rate of 9.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 554.51M | 160.05% |
| Dec 31, 2024 | 213.23M | -75.05% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | 484.97M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.23B |
| Johnson & Johnson | 466.54B |
| AbbVie | 409.95B |
| UnitedHealth Group | 330.10B |
| AstraZeneca | 261.56B |
| Novartis AG | 254.74B |
| Novo Nordisk | 249.65B |
| Abbott Laboratories | 225.41B |